Calvert Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Calvert Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,978	Closed	-$213K	–	803
2016 Q1	$213K	Hold	3,978	–	–	0.01%	686
2015 Q4	$261K	Sell	3,978 -52	-1%	-$3.21K	0.01%	605
2015 Q3	$228K	Hold	4,030	–	–	0.01%	545
2015 Q2	$238K	Buy	+4,030	New	+$249K	0.01%	570
2014 Q3	–	Sell	-3,915	Closed	-$205K	–	598
2014 Q2	$205K	Buy	+3,915	New	+$200K	0.01%	341

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Calvert Investment Management's TEVA Position: Q2 2016 in Review

Calvert Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2016, closing a stake of 3,978 shares — an estimated $213K sold.

Calvert Investment Management first reported a position in TEVA in Q2 2014 and held it in 5 quarters. The position peaked at $261K in Q4 2015. 812 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

Calvert Investment Management reported no remaining Teva Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
Calvert Investment Management sold 3,978 Teva Pharmaceuticals shares in Q2 2016, an estimated $213K.
Calvert Investment Management first reported a position in Teva Pharmaceuticals in Q2 2014 and held it in 5 quarters.
Calvert Investment Management's Teva Pharmaceuticals position peaked at $261K in Q4 2015.
812 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2016.

Based on Calvert Investment Management's 13F filing for Q2 2016, filed 4 Aug 2016.